Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH

NCT05936086 is registered in ClinicalTrials.gov with shifeng Lou as lead sponsor.

NCT NCT05936086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05936086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH
Lead sponsor
shifeng Lou
Phase
Not applicable
Overall status
Recruiting
Start date
April 20, 2023
Completion date
May 20, 2027
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophagocytic syndrome